Efficient estimation of the distribution of quality-adjusted survival time

Quality of life is an important aspect in evaluation of clinical trials of chronic diseases, such as cancer and AIDS. Quality-adjusted survival analysis is a method that combines both the quantity and quality of a patient's life into one single measure. In this paper, we discuss the efficiency of weighted estimators for the distribution of quality-adjusted survival time. Using the general representation theorem for missing data processes, we are able to derive an estimator that is more efficient than the one proposed in Zhao and Tsiatis (1997, Biometrika 84, 339-348). Simulation experiments are conducted to assess the small sample properties of this estimator and to compare it with the semiparametric efficiency bound. The value of this estimator is demonstrated from an application of the method to a data set obtained from a breast cancer clinical trial.     

Variance and sample size calculations in quality-of-life--adjusted survival analysis (Q-TWiST)

The Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) statistic previously introduced by Glasziou, Simes and Gelber (1990, Statistics in Medicine 9, 1259-1276) combines toxicity, disease-free survival, and overall survival information in assessing the impact of treatments on the lives of patients. This methodology has received positive reviews from clinicians as intuitive and useful, but to date, the variance of this statistic has remained unspecified. We review aspects of the Q-TWiST method for analyzing clinical trial data, extend the method to accommodate multiple treatment arms, and provide closed-form asymptotic variance formulas. We also provide a framework for designing Q-TWiST clinical trials with sample sizes determined using the derived asymptotic variance formulas. Trials currently collecting quality of life data did not have the benefit of these sample size calculation techniques in designing their studies.     

Nonparametric estimation of a Markov 'illness-death' process from interval-censored observations, with application to diabetes survival data

The nonparametric estimation of the cumulative transition intensityfunctions in a threestate time-nonhomogeneous Markov processwith irreversible transitions, an ‘illness-death’model, is considered when times of the intermediate transition,e.g. onset of a disease, are interval-censored. The times of‘death’ are assumed to be known exactly or to beright-censored. In addition the observed process may be left-truncated.Data of this type arise when the process is sampled periodically.For example, when the patients are monitored through periodicexaminations the observations on times of change in their diseasestatus will be interval-censored. Under the sampling schemeconsidered here the Nelson–Aalen estimator (Aalen, 1978)for a cumulative transition intensity is not applicable. Inthe proposed method the maximum likelihood estimators of someof the transition intensities are derived from the estimatorsof the corresponding subdistribution functions. The maximumlikelihood estimators are shown to have a self-consistency property.The self-consistency algorithm is developed for the computationof the estimators. This approach generalises the results fromTurnbull (1976) and Frydman (1992). The methods are illustratedwith diabetes survival data.     

A group sequential test for survival trials: an alternative to rank-based procedures

A method of interim monitoring is described for survival trials in which the proportional hazards assumption may not hold. This method extends the test statistics based on the cumulative weighted difference in the Kaplan-Meier estimates (Pepe and Fleming, 1989, Biometrics 45, 497-507) to the sequential setting. Therefore, it provides a useful alternative to the group sequential linear rank tests. With an appropriate weight function, the test statistic itself provides an estimator for the cumulative weighted difference in survival probabilities, which is an interpretable measure for the treatment difference, especially when the proportional hazards model fails. The method is illustrated based on the design of a real trial. The operating characteristics are studied through a small simulation.     

A modification of the redistribution to the right algorithm using disease markers

Disease markers are time-dependent covariates which describeprogression towards development of disease. Traditional methodsin survival analysis do not make use of available data on thesemarkers to recover additional information from censored individuals.Using a heuristic modification of the redistribution to theright algorithm (Efron, 1967), a new approach for recoveringinformation for censored individuals using disease markers isproposed. Additionally, the statistical properties of the proposedmethod are examined. There are two possible advantages to thismodification: (i) bias reduction when censoring is informative,and (ii) an increase in efficiency in the case of truly noninformativecensoring.     

Regression survival analysis with an assumed copula for dependent censoring: a sensitivity analysis approach

SUMMARY: In clinical studies, when censoring is caused by competing risks or patient withdrawal, there is always a concern about the validity of treatment effect estimates that are obtained under the assumption of independent censoring. Because dependent censoring is nonidentifiable without additional information, the best we can do is a sensitivity analysis to assess the changes of parameter estimates under different assumptions about the association between failure and censoring. This analysis is especially useful when knowledge about such association is available through literature review or expert opinions. In a regression analysis setting, the consequences of falsely assuming independent censoring on parameter estimates are not clear. Neither the direction nor the magnitude of the potential bias can be easily predicted. We provide an approach to do sensitivity analysis for the widely used Cox proportional hazards models. The joint distribution of the failure and censoring times is assumed to be a function of their marginal distributions. This function is called a copula. Under this assumption, we propose an iteration algorithm to estimate the regression parameters and marginal survival functions. Simulation studies show that this algorithm works well. We apply the proposed sensitivity analysis approach to the data from an AIDS clinical trial in which 27% of the patients withdrew due to toxicity or at the request of the patient or investigator.     

Flexible hazard regression modeling for medical cost data

The modeling of lifetime (i.e. cumulative) medical cost data in the presence of censored follow-up is complicated by induced informative censoring, rendering standard survival analysis tools invalid. With few exceptions, recently proposed nonparametric estimators for such data do not extend easily to handle covariate information. We propose to model the hazard function for lifetime cost endpoints using an adaptation of the HARE methodology (Kooperberg, Stone, and Truong, Journal of the American Statistical Association, 1995, 90, 78-94). Linear splines and their tensor products are used to adaptively build a model that incorporates covariates and covariate-by-cost interactions without restrictive parametric assumptions. The informative censoring problem is handled using inverse probability of censoring weighted estimating equations. The proposed method is illustrated using simulation and also with data on the cost of dialysis for patients with end-stage renal disease.     

Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status

Summary .  In many clinical trials patients are intermittently assessed for the transition to an intermediate state, such as occurrence of a disease-related nonfatal event, and death. Estimation of the distribution of nonfatal event free survival time, that is, the time to the first occurrence of the nonfatal event or death, is the primary focus of the data analysis. The difficulty with this estimation is that the intermittent assessment of patients results in two forms of incompleteness: the times of occurrence of nonfatal events are interval censored and, when a nonfatal event does not occur by the time of the last assessment, a patient's nonfatal event status is not known from the time of the last assessment until the end of follow-up for death. We consider both forms of incompleteness within the framework of an "illness–death" model. We develop nonparametric maximum likelihood (ML) estimation in an "illness–death" model from interval-censored observations with missing status of intermediate transition. We show that the ML estimators are self-consistent and propose an algorithm for obtaining them. This work thus provides new methodology for the analysis of incomplete data that arise from clinical trials. We apply this methodology to the data from a recently reported cancer clinical trial ( Bonner et al., 2006 , New England Journal of Medicine 354, 567–578) and compare our estimation results with those obtained using a Food and Drug Administration recommended convention.     

Regression analysis of mean quality-adjusted lifetime with censored data

In clinical trials of chronic diseases such as acquired immunodeficiency syndrome, cancer, or cardiovascular diseases, the concept of quality-adjusted lifetime (QAL) has received more and more attention. In this paper, we consider the problem of how the covariates affect the mean QAL when the data are subject to right censoring. We allow a very general form for the mean model as a function of covariates. Using the idea of inverse probability weighting, we first construct a simple weighted estimating equation for the parameters in our mean model. We then find the form of the most efficient estimating equation, which yields the most efficient estimator for the regression parameters. Since the most efficient estimator depends on the distribution of the health history processes, and thus cannot be estimated nonparametrically, we consider different approaches for improving the efficiency of the simple weighted estimating equation using observed data. The applicability of these methods is demonstrated by both simulation experiments and a data example from a breast cancer clinical trial study.     

Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO

We consider the problem of predicting survival times of cancer patients from the gene expression profiles of their tumor samples via linear regression modeling of log-transformed failure times. The partial least squares (PLS) and least absolute shrinkage and selection operator (LASSO) methodologies are used for this purpose where we first modify the data to account for censoring. Three approaches of handling right censored data-reweighting, mean imputation, and multiple imputation-are considered. Their performances are examined in a detailed simulation study and compared with that of full data PLS and LASSO had there been no censoring. A major objective of this article is to investigate the performances of PLS and LASSO in the context of microarray data where the number of covariates is very large and there are extremely few samples. We demonstrate that LASSO outperforms PLS in terms of prediction error when the list of covariates includes a moderate to large percentage of useless or noise variables; otherwise, PLS may outperform LASSO. For a moderate sample size (100 with 10,000 covariates), LASSO performed better than a no covariate model (or noise-based prediction). The mean imputation method appears to best track the performance of the full data PLS or LASSO. The mean imputation scheme is used on an existing data set on lung cancer. This reanalysis using the mean imputed PLS and LASSO identifies a number of genes that were known to be related to cancer or tumor activities from previous studies.